Skip to main content

Breadcrumb

  1. Home

SynCardia CardioWest TAH-t Postmarket Surveillance Study

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about SynCardia CardioWest TAH-t Postmarket Surveillance Study

Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF

Assessment of LBR-101 In Chronic Migraine

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Assessment of LBR-101 In Chronic Migraine

Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori

Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea

Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis

Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS

Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure

An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum

A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 68
  • Page 69
  • Page 70
  • Page 71
  • Page 72
  • Page 73
  • Page 74
  • Page 75
  • Page 76
  • …
  • Next page Next
  • Last page Last
Subscribe to